AMARIN CORP PLC\UK Inventory, Gross
AMARIN CORP PLC\UK (AMRN) had Inventory, Gross of $76.77 million as of 2019-12-31, per its 10-K filed 2020-02-25.
Discontinued › Notes › Inventory › Inventory, Net › Inventory, Gross
us-gaap:InventoryGross · last filed 2020-02-25
- 2019-12-31: Inventory, Gross $76.77M.
- 2019-09-30: Inventory, Gross $54.72M.
- 2019-06-30: Inventory, Gross $46.43M.
- 2019-03-31: Inventory, Gross $58.07M.
| Period end | Inventory, Gross |
|---|---|
| 2019-12-31 | $76.77M 10-K · filed 2020-02-25 |
| 2019-09-30 | $54.72M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $46.43M 10-Q · filed 2019-07-31 |
| 2019-03-31 | $58.07M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $58.09M 10-K · filed 2020-02-25 |
| 2018-09-30 | $43.96M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $40.51M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $35.42M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $30.26M 10-K · filed 2019-02-27 |
| 2012-12-31 | $21.26M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |